Research progress on the relationship between multiple vitamins and hepatic carcinoma

doi:10.19871/j.cnki.xfcrbzz.2021.03.021

Abstract

Abstract: The morbidity and mortality of hepatic carcinoma have been high in China and the world for years.With the improvement of living standards, a dramatically increasing number of citizens are paying attention to vitamins supplementation. Appropriate and rational use of vitamins is particularly important .Each vitamin has different functions. In recent years, multivitamins have been found to have a certain correlation with hepatic carcinoma. Their application in the prevention and treatment of hepatic carcinoma has also received much attention.The detection of vitamins is convenient and fast, which can predict the progression and prognosis of hepatic carcinoma. Vitamins are economically available and have low side effects, which are expected to become newer and more effective anti-hepatic carcinoma drugs. According to the current research progress at home and abroad, this article reviews the relationship between vitamins and hepatic carcinoma.

Key words: Vitamins, Hepatic carcinoma, Prevention, Therapeutics

Tao Zhu, Wang Yan, Lyu Cheng, Guo Hongli, Zhang Fengdan, Zheng Shuang. Research progress on the relationship between multiple vitamins and hepatic carcinoma[J]. Electronic Journal of Emerging Infectious Diseases, 2021, 6(3): 260-264.

References

[1] 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J]. 临床肝胆病杂志, 2020, 36(2):277-292.
[2] BRAY F, FERLAY J, SOERJOMATARAM I, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2018,68(6):394-424.
[3] WEI D, ZENG Y, XING X, et al.Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics[J]. J Proteome Res,2016,15(2):487-498.
[4] 中华预防医学会肝胆胰疾病预防与控制专业委员会,中国研究型医院学会肝病专业委员会,中华医学会肝病学分会,等. 原发性肝癌的分层筛查与监测指南(2020版)[J]. 中华肝胆外科杂志,2021,27(1):12-29.
[5] DE MARTEL C, GEORGES D, BRAY F, et al.Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis[J]. Lancet Glob Health, 2020, 8(2): e180-e190.
[6] CHEN CJ, YANG HI, ILOEJE UH.Hepatitis B virus DNA levels and outcomes in chronic hepatitis B[J]. Hepatology, 2009, 49(5):S72-S84.
[7] 邵一鸣,苏力德,郝睿,等. 乙型肝炎病毒诱发肝细胞癌分子机制研究进展[J]. 浙江大学学报(医学版), 2021, 50(01):113-122.
[8] KIM BH, PARK JW.Epidemiology of liver cancer in South Korea[J]. Clin Mol Hepatol,2018,24(1):1-9.
[9] 陈洪涛,杨智,吴诗品. 外周血单个核细胞黑色素瘤缺乏因子2在原发性肝癌中的表达及其临床意义[J/CD]. 新发传染病电子杂志,2019,4(03):149-151.
[10] 邬宇美,骆子义,黄华. 原发性肝癌中KRAS及BRAF基因突变检测及临床意义分析[J/CD]. 新发传染病电子杂志, 2018, 3(1):37-40.
[11] KANAZIR M, BORICIC I, DELIC D, et al.Risk factors for hepatocellular carcinoma: a case-control study in Belgrade (Serbia)[J]. Tumori,2010,96(6):911-917.
[12] PHAM T M, FUJINO Y, IDE R, et al.Prospective study of vegetable consumption and liver cancer in Japan[J]. Int J Cancer,2006,119(10):2408-2411.
[13] 温伟省. 维生素类药物滥用的危害及合理使用分析[J]. 中国医药指南,2015,13(14):297-298.
[14] 皮丽娜,候艳莹,张维. 肠道菌群失调、炎症因子变化、维生素缺乏与肝癌患者根治术后复发的关系[J]. 现代肿瘤医学,2019,27(17):3078-3081.
[15] 翦耀文,王雷,刘也,等. 膳食维生素摄入与肝癌发病风险关系的Meta分析[J]. 肿瘤防治研究,2020,47(02):108-111.
[16] CHAVES GV, PERES WA, GONCALVES JC, et al.Vitamin A and retinol-binding protein deficiency among chronic liver disease patients[J]. Nutrition,2015,31(5):664-668.
[17] FORRESTER JE, WANG XD, KNOX TA, et al.Factors associated with serum retinol, alpha-tocopherol, carotenoids, and selenium in Hispanics with problems of HIV, chronic hepatitis C, and drug use[J]. J Public Health Policy,2009,30(3):285-299.
[18] BITETTO D, BORTOLOTTI N, FALLETI E, et al.Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon-based antiviral therapy[J]. Hepatology,2013,57(3):925-933.
[19] PERES WA, CHAVES GV, GONCALVES JC, et al.Vitamin A deficiency in patients with hepatitis C virus-related chronic liver disease[J]. Br J Nutr,2011,106(11):1724-1731.
[20] ARANTES FPW, VILLACA CG, SARAIVA GJ, et al.Assessment of the relative dose-response test as indicators of hepatic vitamin A stores in various stages of chronic liver disease[J]. Nutr Clin Pract,2013,28(1):95-100.
[21] 韩少山,何潇言,姚博文,等. 肝星状细胞与肝癌的关系1[J]. 中华肝胆外科杂志,2016,22(10):711-713.
[22] KATARIA Y, DEATON R J, ENK E, et al.Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer[J]. BMC Gastroenterol,2016,16:30.
[23] 张典,姜凤良,胡志芳,等. 原发性肝癌的预防措施[J]. 中国老年学杂志,2018,38(17):4317-4319.
[24] LAN QY, ZHANG YJ, LIAO GC, et al.The Association between Dietary Vitamin A and Carotenes and the Risk of Primary Liver Cancer: A Case-Control Study[J]. Nutrients,2016,8(10):624.
[25] MUTO Y, MORIWAKI H, NINOMIYA M, et al.Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group[J]. N Engl J Med,1996,334(24):1561-1567.
[26] 赵翰卿,李欣怡,汪瑞琦,等. 维生素家族对免疫细胞影响的研究进展[J]. 生命科学,2020,32(04):343-348.
[27] 周瑞芬,陈晓玲,兰秋野,等. 膳食叶酸、维生素B6、维生素B12摄入量与原发性肝癌关系的病例对照研究[J]. 热带医学杂志,2016(16):5-9.
[28] LEE D, XU IM, CHIU DK, et al.Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma[J]. J Clin Invest,2017,127(5):1856-1872.
[29] 党海燕. 肝细胞癌患者血清维生素B(12)水平检测的临床意义[J]. 国外医学(医学地理分册),2018,39(03):231-233.
[30] CUI LH, QUAN ZY, PIAO JM, et al.Plasma Folate and Vitamin B12 Levels in Patients with Hepatocellular Carcinoma[J]. Int J Mol Sci,2016,17(7):1032.
[31] IVANCOVSKY-WAJCMAN D, FLISS-ISAKOV N, SALOMONE F, et al.Dietary vitamin E and C intake is inversely associated with the severity of nonalcoholic fatty liver disease[J]. Dig Liver Dis,2019,51(12):1698-1705.
[32] SRAM RJ, BINKOVA B, ROSSNER PJ.Vitamin C for DNA damage prevention[J]. Mutat Res,2012,733(1-2):39-49.
[33] ZHANG W, SHU XO, LI H, et al.Vitamin Intake and Liver Cancer Risk: A Report From Two Cohort Studies in China[J]. J Natl Cancer Inst,2012,104(15):1174-1182.
[34] LEVINE M, CONRY-CANTILENA C, WANG Y, et al.Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance[J]. Proc Natl Acad Sci USA,1996,93(8):3704-3709.
[35] 李军袖,郭朝瑞,帆封,等. 维生素C在肿瘤治疗中的研究概况[J]. 海峡药学,2016,9(28):1-4.
[36] LV H, WANG C, FANG T, et al.Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2[J]. NPJ Precis Oncol,2018,2(1):1.
[37] ZHAO F, ZHAO J, SONG L, et al.The induction of apoptosis and autophagy in human hepatoma SMMC-7721 cells by combined treatment with vitamin C and polysaccharides extracted from Grifola frondosa[J]. Apoptosis,2017,22(11):1461-1472.
[38] ROULEAU L, ANTONY AN, BISETTO S, et al.Synergistic effects of ascorbate and sorafenib in hepatocellular carcinoma: New insights into ascorbate cytotoxicity[J]. Free Radic Biol Med,2016,95:308-322.
[39] 张明君,杨继红. 维生素D的新认识[J]. 中国全科医学, 2018,21(20):2395-2399.
[40] DIAZ L, DIAZ-MUNOZ M, GARCIA-GAYTAN AC, et al.Mechanistic Effects of Calcitriol in Cancer Biology[J]. Nutrients,2015,7(6):5020-5050.
[41] LUONG K, NGUYEN LT.Theoretical basis of a beneficial role for vitamin D in viral hepatitis[J]. World J Gastroenterol,2012,18(38):5338-5350.
[42] FARNIK H, BOJUNGA J, BERGER A, et al.Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients[J]. Hepatology,2013,58(4):1270-1276.
[43] ARTEH J, NARRA S, NAIR S.Prevalence of vitamin D deficiency in chronic liver disease[J]. Dig Dis Sci,2010,55(9):2624-2628.
[44] 邢时龙,淦勤. 原发性肝癌患者血清25-羟基维生素D_3水平与免疫抑制因子IL-10的关系[J]. 医学信息, 2020, 33(1):101-103.
[45] LI S, GUO X, LI D.A higher circulating vitamin D was inversely associated with liver cancer risk: a meta-analysis of prospective studies[C]. 中国江苏南京:2019.
[46] CAI L, LUO L, TANG Z, et al.Combined antitumor effects of 1,25dihydroxy vitamin D3 and Notch inhibitor in liver cancer[J]. Oncol Rep,2018,40(3):1515-1524.
[47] FINKELMEIER F, KRONENBERGER B, KOBERLE V, et al.Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma - a prospective cohort study[J]. Aliment Pharmacol Ther,2014,39(10):1204-1212.
[48] CHEN E, SHI Y, TANG H.New insight of vitamin D in chronic liver diseases[J]. Hepatobiliary & Pancreatic Diseases International,2014,13(6):580-585.
[49] 张静姝,李大鸣. 生育三烯酚抗肿瘤机制研究进展[J]. 中国慢性病预防与控制,2012,20(5):604-608.
[50] SIVEEN KS, AHN KS, ONG TH, et al.γ -tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model[J]. Oncotarget, 2014, 5(7):1897-1911.
[51] ABDUL R SF, JUBRI Z, ABDUL RM, et al.Gamma-tocotrienol treatment increased peroxiredoxin-4 expression in HepG2 liver cancer cell line[J]. BMC Complement Altern Med,2015,15:64.
[52] 张小丽,刘佳,马玉芳,等. 血清维生素E和胡萝卜素β以及维生素A与原发性肝癌死亡率的相关性研究[J]. 中国全科医学,2017,20(20):2474-2479.
[53] 梁俊英,朱文彬. 浅谈维生素[J]. 医药前沿,2017,9(7):318-319.
[54] 陈丽,付丹,熊玲,等. 维生素K1对HCC患者TACE治疗后外周血DCP水平的影响[J]. 西南国防医药,2019,29(4):412-415.
[55] 闫瑞承,罗建飞,沈世强. 维生素K2联合磷脂酰胆碱抑制人肝癌细胞作用机制的生物信息学分析[J]. 中华实验外科杂志,2019(10):1738-1740.
[56] 孔令玉,路欣,姜玲玲. 维生素K_2通过降低D-双功能蛋白活性抑制肝癌的实验研究[J]. 疑难病杂志,2020,19(1):75-79.
[57] RIAZ I B, RIAZ H, RIAZ T, et al.Role of vitamin K2 in preventing the recurrence of hepatocellular carcinoma after curative treatment: a meta-analysis of randomized controlled trials[J]. BMC Gastroenterol,2012,12:170.
[58] JINGHE X, MIZUTA T, OZAKI I.Vitamin K and hepatocellular carcinoma: The basic and clinic[J]. World J Clin Cases,2015,3(9):757-764.
[59] 奉涛. 滥用维生素类药物的危害及其防治对策[J]. 临床合理用药杂志,2010,3(23):40-41.